[Proceedings of The National Academy of Sciences of The United States of America] Investigators reported significant transcriptomic signatures of Cas13bt3 expression in retinal cells and show all-in-one adeno-associated virus gene therapy with Cas13bt3 can effectively silence VEGFA mRNA in human retinal organoids and humanized VEGF transgenic mouse models.
[Pharmacy Times] The FDA granted an accelerated approval to asciminib for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase.
[Nature Immunology] Investigators showed that mice harboring the corresponding Bcl11bN440K mutation show the emergence of natural killer/group 1 innate lymphoid cell-like NKp46+ cells in the thymus and reduction in TBR1+ neurons in the neocortex, which were observed with loss of Bcl11a but not Bcl11b.
[Nature Communications] Scientists reported a self-assembled nano-prodrug composed of aldehyde dehydrogenases activatable photosensitizer and disulfide-linked all-trans retinoic acid for diagnosis and targeted treatment of CSCs enriched tumors.
Investigators combined multicolor lineage tracing with chemical mutagenesis in mice to show that a large proportion of intestinal tumours have a multiancestral origin. Polyclonal tumors retained a structure comprising subclones with...
Crosstalk between vascular endothelial cells and fibroblasts in Idiopathic Pulmonary Fibrosis mediated by bone morphogenic protein signalling may be important for remodeling of the lung. A novel modality for monitoring...
[Blood] To model in vivo cancer stem cell/tumor microenvironment interactions and elucidate their functional consequences, scientists focused on myelofibrosis, a stem cell driven myeloproliferative neoplasm.
[Journal of Experimental Medicine] Researchers reported that shear stress triggers adaptation in mitochondrial composition, ultrastructure, and function, which are essential for hematopoietic fate and engraftment potential.
[Cell Reports] The authors reported that expression of the ribosomal protein RPL22 is frequently reduced in human myelodysplastic syndrome and AML, and reduced RPL22 expression is associated with worse outcomes.